APO RESEARCH · REPORT
Plasminogen
Plasminogen, the proenzyme of the fibrinolytically active enzyme plasmin, is a single chain glycoprotein with a molecular weight of about 90,000-94,000 Da (2). Various isoelectric forms exist and can be separated by means of isoelectric focusing (IEF). The complete amino acid sequence contains 790 amino acids. Native plasminogen (glu-plasminogen) has a N-terminal glutamic acid group. Partial plasma proteolysis gives rise to a molecule with N-terminal lysine (lysplasminogen). Currently, the product has obtained the designation of orphan drug by the US Food and Drug Administration (FDA) and by the European Medicines Agency (EMA). Clinical trials are still underway to obtain Marketing Authorization in the United States and in Europe (EU). The report mainly targeting the research status, predicted competitive landscape, market potential and future trends of plasminogen market.
Product & engineering
Understand the product.
Plasminogen, the proenzyme of the fibrinolytically active enzyme plasmin, is a single chain glycoprotein with a molecular weight of about 90,000-94,000 Da (2). Various isoelectric forms exist and can be separated by means of isoelectric focusing (IEF). The complete amino acid sequence contains 790 amino acids. Native plasminogen (glu-plasminogen) has a N-terminal glutamic acid group. Partial plasma proteolysis gives rise to a molecule with N-terminal lysine (lysplasminogen). Currently, the product has obtained the designation of orphan drug by the US Food and Drug Administration (FDA) and by the European Medicines Agency (EMA). Clinical trials are still underway to obtain Marketing Authorization in the United States and in Europe (EU). The report mainly targeting the research status, predicted competitive landscape, market potential and future trends of plasminogen market.
Selected research
Industry Growth & Trends
Global Plasminogen Industry Growth and Trends Forecast to 2032
Market perspective
Plasminogen, the proenzyme of the fibrinolytically active enzyme plasmin, is a single chain glycoprotein with a molecular weight of about 90,000-94,000 Da (2). Various isoelectric forms exist and can be separated by means of isoelectric focusing (IEF). The complete amino acid sequence contains 790 amino acids. Native plasminogen (glu-plasminogen) has a N-terminal glutamic acid group. Partial plasma proteolysis gives rise to a molecule with N-terminal lysine (lysplasminogen). Currently, the product has obtained the designation of orphan drug by the US Food and Drug Administration (FDA) and by the European Medicines Agency (EMA). Clinical trials are still underway to obtain Marketing Authorization in the United States and in Europe (EU). The report mainly targeting the research status, predicted competitive landscape, market potential and future trends of plasminogen market.
Global Plasminogen key players include Kedrion, Prometic, Genentech (Roche), Boehringer Ingelheim, Kyowa Hakko Kirin, etc. North America is the largest market, with a share about 45%, followed by Europe, with a share about 20 percent. In terms of product, Eye Drops is the largest segment, with a share about 88%.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Plasminogen market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Plasminogen market size, estimates, and forecasts are presented in terms of sales volume (MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Plasminogen market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Plasminogen.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Plasminogen market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Plasminogen Market by Company
Kedrion
Prometic
Genentech (Roche)
Boehringer Ingelheim
Kyowa Hakko Kirin
Omeros Corporation
Plasminogen Segment by Type
Intravenous Injection
Eye Drops
Plasminogen Segment by Application
Ligneous Conjunctivitis
Diabetic Foot
Wound Healing
Others
Plasminogen Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasminogen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasminogen and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasminogen.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plasminogen manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Plasminogen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Intravenous Injection
- Eye Drops
Applications
- Ligneous Conjunctivitis
- Diabetic Foot
- Wound Healing
- Others
Companies covered
- Kedrion
- Prometic
- Genentech (Roche)
- Boehringer Ingelheim
- Kyowa Hakko Kirin
- Omeros Corporation
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Plasminogen Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Plasminogen Sales Estimates and Forecasts (2021-2032)
- 1.3 Plasminogen Market by Type
- 1.3.1 Intravenous Injection
- 1.3.2 Eye Drops
- 1.4 Global Plasminogen Market Size by Type
- 1.4.1 Global Plasminogen Market Size Overview by Type (2021-2032)
- 1.4.2 Global Plasminogen Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Plasminogen Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Plasminogen Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Plasminogen Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Plasminogen Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Plasminogen Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Plasminogen Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Plasminogen Industry Trends
- 2.2 Plasminogen Industry Drivers
- 2.3 Plasminogen Industry Opportunities and Challenges
- 2.4 Plasminogen Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Plasminogen Revenue (2021-2026)
- 3.2 Global Top Players by Plasminogen Sales (2021-2026)
- 3.3 Global Top Players by Plasminogen Price (2021-2026)
- 3.4 Global Plasminogen Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Plasminogen Major Company Production Sites & Headquarters
- 3.6 Global Plasminogen Company, Product Type & Application
- 3.7 Global Plasminogen Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Plasminogen Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Plasminogen Players Market Share by Revenue in 2025
- 3.8.3 2025 Plasminogen Tier 1, Tier 2, and Tier 3
4 Plasminogen Regional Status and Outlook
- 4.1 Global Plasminogen Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Plasminogen Historic Market Size by Region
- 4.2.1 Global Plasminogen Sales in Volume by Region (2021-2026)
- 4.2.2 Global Plasminogen Sales in Value by Region (2021-2026)
- 4.2.3 Global Plasminogen Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Plasminogen Forecasted Market Size by Region
- 4.3.1 Global Plasminogen Sales in Volume by Region (2027-2032)
- 4.3.2 Global Plasminogen Sales in Value by Region (2027-2032)
- 4.3.3 Global Plasminogen Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Plasminogen by Application
- 5.1 Plasminogen Market by Application
- 5.1.1 Ligneous Conjunctivitis
- 5.1.2 Diabetic Foot
- 5.1.3 Wound Healing
- 5.1.4 Others
- 5.2 Global Plasminogen Market Size by Application
- 5.2.1 Global Plasminogen Market Size Overview by Application (2021-2032)
- 5.2.2 Global Plasminogen Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Plasminogen Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Plasminogen Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Plasminogen Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Plasminogen Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Plasminogen Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Plasminogen Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Kedrion
- 6.1.1 Kedrion Company Information
- 6.1.2 Kedrion Business Overview
- 6.1.3 Kedrion Plasminogen Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Kedrion Plasminogen Product Portfolio
- 6.1.5 Kedrion Recent Developments
- 6.2 Prometic
- 6.2.1 Prometic Company Information
- 6.2.2 Prometic Business Overview
- 6.2.3 Prometic Plasminogen Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Prometic Plasminogen Product Portfolio
- 6.2.5 Prometic Recent Developments
- 6.3 Genentech (Roche)
- 6.3.1 Genentech (Roche) Company Information
- 6.3.2 Genentech (Roche) Business Overview
- 6.3.3 Genentech (Roche) Plasminogen Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Genentech (Roche) Plasminogen Product Portfolio
- 6.3.5 Genentech (Roche) Recent Developments
- 6.4 Boehringer Ingelheim
- 6.4.1 Boehringer Ingelheim Company Information
- 6.4.2 Boehringer Ingelheim Business Overview
- 6.4.3 Boehringer Ingelheim Plasminogen Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Boehringer Ingelheim Plasminogen Product Portfolio
- 6.4.5 Boehringer Ingelheim Recent Developments
- 6.5 Kyowa Hakko Kirin
- 6.5.1 Kyowa Hakko Kirin Company Information
- 6.5.2 Kyowa Hakko Kirin Business Overview
- 6.5.3 Kyowa Hakko Kirin Plasminogen Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Kyowa Hakko Kirin Plasminogen Product Portfolio
- 6.5.5 Kyowa Hakko Kirin Recent Developments
- 6.6 Omeros Corporation
- 6.6.1 Omeros Corporation Company Information
- 6.6.2 Omeros Corporation Business Overview
- 6.6.3 Omeros Corporation Plasminogen Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Omeros Corporation Plasminogen Product Portfolio
- 6.6.5 Omeros Corporation Recent Developments
7 North America by Country
- 7.1 North America Plasminogen Sales by Country
- 7.1.1 North America Plasminogen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Plasminogen Sales by Country (2021-2026)
- 7.1.3 North America Plasminogen Sales Forecast by Country (2027-2032)
- 7.2 North America Plasminogen Market Size by Country
- 7.2.1 North America Plasminogen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Plasminogen Market Size by Country (2021-2026)
- 7.2.3 North America Plasminogen Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Plasminogen Sales by Country
- 8.1.1 Europe Plasminogen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Plasminogen Sales by Country (2021-2026)
- 8.1.3 Europe Plasminogen Sales Forecast by Country (2027-2032)
- 8.2 Europe Plasminogen Market Size by Country
- 8.2.1 Europe Plasminogen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Plasminogen Market Size by Country (2021-2026)
- 8.2.3 Europe Plasminogen Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Plasminogen Sales by Country
- 9.1.1 Asia-Pacific Plasminogen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Plasminogen Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Plasminogen Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Plasminogen Market Size by Country
- 9.2.1 Asia-Pacific Plasminogen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Plasminogen Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Plasminogen Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Plasminogen Sales by Country
- 10.1.1 South America Plasminogen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Plasminogen Sales by Country (2021-2026)
- 10.1.3 South America Plasminogen Sales Forecast by Country (2027-2032)
- 10.2 South America Plasminogen Market Size by Country
- 10.2.1 South America Plasminogen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Plasminogen Market Size by Country (2021-2026)
- 10.2.3 South America Plasminogen Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Plasminogen Sales by Country
- 11.1.1 Middle East and Africa Plasminogen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Plasminogen Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Plasminogen Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Plasminogen Market Size by Country
- 11.2.1 Middle East and Africa Plasminogen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Plasminogen Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Plasminogen Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Plasminogen Value Chain Analysis
- 12.1.1 Plasminogen Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Plasminogen Production Mode & Process
- 12.2 Plasminogen Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Plasminogen Distributors
- 12.2.3 Plasminogen Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst